RankingsPricing
  1. JP-listed companies
  2. ReproCELL Incorporated
  3. Financials
  4. Total current liabilities

ReproCELL IncorporatedJP:4978

Market cap
¥14.1B
P/E ratio
-188.6x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndTotal current liabilities (Million JPY)YoY (%)
Mar 31, 2025641-5.57%
Mar 31, 2024678-9.51%
Mar 31, 2023750-9.38%
Mar 31, 2022827+49.48%
Mar 31, 2021553+36.00%
Mar 31, 2020407+23.16%
Mar 31, 2019330+26.59%
Mar 31, 2018261-7.40%
Mar 31, 2017282-38.23%
Mar 31, 2016456+52.50%
Mar 31, 2015299

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)